Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Childhood emotional invalidation and right hemispheric mu suppression during a pain empathy task: An EEG study.

Arnett K, Roach A, Elzy M, Jelsone-Swain L.

Soc Neurosci. 2019 Apr;14(2):236-250. doi: 10.1080/17470919.2018.1441905. Epub 2018 Mar 4.

PMID:
29451071
2.

Interactions with the healthcare system influence advance care planning activities: results from a representative survey in 11 developed countries.

Sable-Smith A, Arnett KR, Nowels MA, Colborn K, Lum HD, Nowels D.

Fam Pract. 2018 May 23;35(3):307-311. doi: 10.1093/fampra/cmx113.

3.

16p11.2 Microduplication and associated symptoms: A case study.

Knoll M, Arnett K, Hertza J.

Appl Neuropsychol Child. 2018 Oct-Dec;7(4):374-379. doi: 10.1080/21622965.2017.1326046. Epub 2017 May 22.

PMID:
28532165
4.

Genome-wide identification and characterization of Notch transcription complex-binding sequence-paired sites in leukemia cells.

Severson E, Arnett KL, Wang H, Zang C, Taing L, Liu H, Pear WS, Shirley Liu X, Blacklow SC, Aster JC.

Sci Signal. 2017 May 2;10(477). pii: eaag1598. doi: 10.1126/scisignal.aag1598.

5.

Advance Care Planning: Understanding Clinical Routines and Experiences of Interprofessional Team Members in Diverse Health Care Settings.

Arnett K, Sudore RL, Nowels D, Feng CX, Levy CR, Lum HD.

Am J Hosp Palliat Care. 2017 Dec;34(10):946-953. doi: 10.1177/1049909116666358. Epub 2016 Sep 6.

6.

Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.

Henao-Tamayo MI, Obregón-Henao A, Arnett K, Shanley CA, Podell B, Orme IM, Ordway DJ.

J Leukoc Biol. 2016 Apr;99(4):605-17. doi: 10.1189/jlb.4A0614-308RR. Epub 2015 Nov 20.

7.

Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.

Obregón-Henao A, Arnett KA, Henao-Tamayo M, Massoudi L, Creissen E, Andries K, Lenaerts AJ, Ordway DJ.

Antimicrob Agents Chemother. 2015 Nov;59(11):6904-12. doi: 10.1128/AAC.00459-15. Epub 2015 Aug 24.

8.

Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.

Yashiro-Ohtani Y, Wang H, Zang C, Arnett KL, Bailis W, Ho Y, Knoechel B, Lanauze C, Louis L, Forsyth KS, Chen S, Chung Y, Schug J, Blobel GA, Liebhaber SA, Bernstein BE, Blacklow SC, Liu XS, Aster JC, Pear WS.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E4946-53. doi: 10.1073/pnas.1407079111. Epub 2014 Nov 4.

9.

Analyzing the nuclear complexes of Notch signaling by electrophoretic mobility shift assay.

Arnett KL, Blacklow SC.

Methods Mol Biol. 2014;1187:231-45. doi: 10.1007/978-1-4939-1139-4_18.

10.

Relational and item-specific influences on generate-recognize processes in recall.

Guynn MJ, McDaniel MA, Strosser GL, Ramirez JM, Castleberry EH, Arnett KH.

Mem Cognit. 2014 Feb;42(2):198-211. doi: 10.3758/s13421-013-0341-6.

PMID:
24425424
11.

NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers.

Wang H, Zang C, Taing L, Arnett KL, Wong YJ, Pear WS, Blacklow SC, Liu XS, Aster JC.

Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):705-10. doi: 10.1073/pnas.1315023111. Epub 2013 Dec 27.

12.

T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.

Germar K, Dose M, Konstantinou T, Zhang J, Wang H, Lobry C, Arnett KL, Blacklow SC, Aifantis I, Aster JC, Gounari F.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20060-5. doi: 10.1073/pnas.1110230108. Epub 2011 Nov 22.

13.

Cerebrovascular disease in 48 countries: secular trends in mortality 1950-2005.

Mirzaei M, Truswell AS, Arnett K, Page A, Taylor R, Leeder SR.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):138-45. doi: 10.1136/jnnp-2011-300408. Epub 2011 Oct 21.

PMID:
22019549
14.

Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.

Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17761-6. doi: 10.1073/pnas.1114669108. Epub 2011 Oct 17.

15.

Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.

Grover A, Troudt J, Arnett K, Izzo L, Lucas M, Strain K, McFarland C, Hall Y, McMurray D, Williams A, Dobos K, Izzo A.

Tuberculosis (Edinb). 2012 Jan;92(1):105-11. doi: 10.1016/j.tube.2011.09.003. Epub 2011 Oct 1.

16.

Activity-based metagenomic screening and biochemical characterization of bovine ruminal protozoan glycoside hydrolases.

Findley SD, Mormile MR, Sommer-Hurley A, Zhang XC, Tipton P, Arnett K, Porter JH, Kerley M, Stacey G.

Appl Environ Microbiol. 2011 Nov;77(22):8106-13. doi: 10.1128/AEM.05925-11. Epub 2011 Sep 23.

17.

Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.

Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, Pear WS, Schug J, Blacklow SC, Arnett KL, Bernstein BE, Kieff E, Aster JC.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14908-13. doi: 10.1073/pnas.1109023108. Epub 2011 Jul 7.

18.

Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infection.

Yang H, Troudt J, Grover A, Arnett K, Lucas M, Cho YS, Bielefeldt-Ohmann H, Taylor J, Izzo A, Dobos KM.

Infect Immun. 2011 Feb;79(2):716-23. doi: 10.1128/IAI.00486-10. Epub 2010 Dec 6.

19.

Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes.

Arnett KL, Hass M, McArthur DG, Ilagan MX, Aster JC, Kopan R, Blacklow SC.

Nat Struct Mol Biol. 2010 Nov;17(11):1312-7. doi: 10.1038/nsmb.1938. Epub 2010 Oct 24.

20.

Notch dimerization is required for leukemogenesis and T-cell development.

Liu H, Chi AW, Arnett KL, Chiang MY, Xu L, Shestova O, Wang H, Li YM, Bhandoola A, Aster JC, Blacklow SC, Pear WS.

Genes Dev. 2010 Nov 1;24(21):2395-407. doi: 10.1101/gad.1975210. Epub 2010 Oct 8.

21.

Expression, purification, crystallization and preliminary X-ray analysis of Pseudomonas aeruginosa AlgX.

Weadge JT, Yip PP, Robinson H, Arnett K, Tipton PA, Howell PL.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 May 1;66(Pt 5):588-91. doi: 10.1107/S1744309110011851. Epub 2010 Apr 30.

22.

Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Grover A, Taylor J, Troudt J, Keyser A, Arnett K, Izzo L, Rholl D, Izzo A.

Infect Immun. 2009 Nov;77(11):4837-46. doi: 10.1128/IAI.00704-09. Epub 2009 Sep 8.

23.

Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.

Aagaard C, Hoang TT, Izzo A, Billeskov R, Troudt J, Arnett K, Keyser A, Elvang T, Andersen P, Dietrich J.

PLoS One. 2009 Jun 16;4(6):e5930. doi: 10.1371/journal.pone.0005930.

24.

Autonomous low-power magnetic data collection platform to enable remote high latitude array deployment.

Musko SB, Clauer CR, Ridley AJ, Arnett KL.

Rev Sci Instrum. 2009 Apr;80(4):044501. doi: 10.1063/1.3108527.

PMID:
19405679
25.

The molecular logic of Notch signaling--a structural and biochemical perspective.

Gordon WR, Arnett KL, Blacklow SC.

J Cell Sci. 2008 Oct 1;121(Pt 19):3109-19. doi: 10.1242/jcs.035683. Review.

26.

The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity.

Reifenberger MS, Arnett KL, Gatto C, Milanick MA.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F1191-8. doi: 10.1152/ajprenal.90296.2008. Epub 2008 Aug 13.

27.
28.

Extracellular terbium and divalent cation effects on the red blood cell Na pump and chrysoidine effects on the renal Na pump.

Reifenberger MS, Arnett KL, Gatto C, Milanick MA.

Blood Cells Mol Dis. 2007 Jul-Aug;39(1):7-13. Epub 2007 Apr 25.

PMID:
17459735
29.

Similarities and differences between organic cation inhibition of the Na,K-ATPase and PMCA.

Gatto C, Helms JB, Prasse MC, Huang SY, Zou X, Arnett KL, Milanick MA.

Biochemistry. 2006 Nov 7;45(44):13331-45.

PMID:
17073454
30.

Ion neutral mass spectrometer results from the first flyby of Titan.

Waite JH Jr, Niemann H, Yelle RV, Kasprzak WT, Cravens TE, Luhmann JG, McNutt RL, Ip WH, Gell D, De La Haye V, Müller-Wordag I, Magee B, Borggren N, Ledvina S, Fletcher G, Walter E, Miller R, Scherer S, Thorpe R, Xu J, Block B, Arnett K.

Science. 2005 May 13;308(5724):982-6.

31.

Kinetic characterization of tetrapropylammonium inhibition reveals how ATP and Pi alter access to the Na+-K+-ATPase transport site.

Gatto C, Helms JB, Prasse MC, Arnett KL, Milanick MA.

Am J Physiol Cell Physiol. 2005 Aug;289(2):C302-11. Epub 2005 Mar 23.

32.

Crystal structure of a human CD3-epsilon/delta dimer in complex with a UCHT1 single-chain antibody fragment.

Arnett KL, Harrison SC, Wiley DC.

Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16268-73. Epub 2004 Nov 8.

33.

Bretylium, an organic quaternary amine, inhibits the Na,K-ATPase by binding to the extracellular K-site.

Helms JB, Arnett KL, Gatto C, Milanick MA.

Blood Cells Mol Dis. 2004 May-Jun;32(3):394-400.

PMID:
15121098
34.

Inhibition of the Na,K-ATPase by the antiarrhythmic drug, Bretylium.

Gatto C, Barkulis CT, Schneider WR, Holden JP, Arnett KL, Milanick MA.

Ann N Y Acad Sci. 2003 Apr;986:620-2. No abstract available.

PMID:
12763901
35.

Chloro(2,2':6',2"-terpyridine) platinum inhibition of the renal Na+,K+-ATPase.

Ruddock NT, Arnett KL, Wilson BJ, Milanick MA.

Am J Physiol Cell Physiol. 2003 Jun;284(6):C1584-92. Epub 2003 Jan 29.

36.
37.

The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells.

Arnett KL, Huang W, Valiante NM, Barber LD, Parham P.

Immunogenetics. 1998 Jun;48(1):56-61.

PMID:
9601944
38.

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P.

Immunity. 1997 Dec;7(6):739-51.

39.

Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas.

Parham P, Arnett KL, Adams EJ, Little AM, Tees K, Barber LD, Marsh SG, Ohta T, Markow T, Petzl-Erler ML.

Tissue Antigens. 1997 Sep;50(3):219-32.

PMID:
9331945
40.

A new HLA-B44 variant (B44BO [B*4408]) identified by serology.

Darke C, Street J, Fussell H, Thomas M, Guttridge M, Goldberg TE, Arnett KL, Parham P.

Tissue Antigens. 1997 Jul;50(1):32-7.

PMID:
9243752
41.

Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.

Barber LD, Percival L, Arnett KL, Gumperz JE, Chen L, Parham P.

J Immunol. 1997 Feb 15;158(4):1660-9.

PMID:
9029102
42.

On the sequence of A*3101.

Arnett KL, Adams EJ, Parham P.

Tissue Antigens. 1996 May;47(5):428-30. No abstract available.

PMID:
8795145
43.

The presence of HLA-A*2403 and HLA-B*1512 on the same haplotype in a Thai family.

Chandanayingyong D, Adams EJ, Arnett KL, Hildebrand WH, Parham P, Lau M.

Tissue Antigens. 1996 May;47(5):426-7. No abstract available.

PMID:
8795144
44.

HLA-A *2607: sequence of a novel A*26 subtype predicted by DNA typing which shares the MA2.1 epitope with A*02, B*57 and B*58.

Arnett KL, Moses JH, Williams F, Marsh SG, Bodmer JG, Parham P, Middleton D.

Tissue Antigens. 1996 May;47(5):422-5. No abstract available.

PMID:
8795143
45.

The presentation of a hepatitis C viral peptide by distinct major histocompatibility complex class I allotypes from two chimpanzee species.

Cooper S, Kowalski H, Erickson AL, Arnett K, Little AM, Walker CM, Parham P.

J Exp Med. 1996 Feb 1;183(2):663-8.

46.

Three new HLA-B alleles found in Mexican-Americans.

Adams EJ, Little AM, Arnett KL, McAuley JE, Williams RC, Parham P.

Tissue Antigens. 1995 Nov;46(5):414-16. No abstract available.

PMID:
8838356
47.

Homogeneity of allelic sequence for serological variants of HLA-B53.

Adams EJ, Scott I, Shah A, Arnett KL, Marsh SG, Madrigal JA, Parham P.

Tissue Antigens. 1995 Oct;46(4):330-2. No abstract available.

PMID:
8560454
48.

Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].

Arnett KL, Adams EJ, Gumperz JE, Darke C, Marsh SG, Gelsthorpe K, Parham P.

Tissue Antigens. 1995 Oct;46(4):316-21.

PMID:
8560451
49.

HLA class I nucleotide sequences, 1995.

Arnett KL, Parham P.

Tissue Antigens. 1995 Sep;46(3 ( Pt 2)):217-57. No abstract available.

PMID:
8525484
50.

Identification of a novel HLA-B40 allele (B*4008) in a patient with leukemia.

Adams EJ, Little AM, Arnett KL, Leushner J, Parham P.

Tissue Antigens. 1995 Sep;46(3 ( Pt 1)):204-5. No abstract available.

PMID:
8525480

Supplemental Content

Loading ...
Support Center